Immunogenicity of SARS-CoV-2 Vaccine in Dialysis

BACKGROUND: Patients receiving maintenance dialysis represent a high risk, immune-compromised population with 15-25% COVID mortality rate who were unrepresented in clinical trials evaluated for mRNA vaccines’ emergency use authorization. METHOD: All patients receiving maintenance dialysis that recei...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:medRxiv
Huvudupphovsmän: Lacson, Eduardo, Argyropoulos, Christos P., Manley, Harold J., Aweh, Gideon, Chin, Andrew I., Salman, Loay H., Hsu, Caroline M., Johnson, Doug S., Weiner, Daniel E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Cold Spring Harbor Laboratory 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8057250/
https://ncbi.nlm.nih.gov/pubmed/33880482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.08.21254779
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk